The role of respiratory viruses in adult patients with cystic fibrosis receiving intravenous antibiotics for a pulmonary exacerbation

Journal of Cystic Fibrosis

Volumn 13, Issue 1, 2014, Pages 49-55

  Etherington, C ^a   Naseer, R ^a   Conway, S P ^a   Whitaker, P ^a   Denton, M ^b   Peckham, D G ^a  

^a ST JAMES S UNIVERSITY HOSPITAL   (United Kingdom)

^b LEEDS GENERAL INFIRMARY   (United Kingdom)

Author keywords

Cystic fibrosis; Polymerase chain reaction; Pulmonary exacerbation; Respiratory viruses; Rhinovirus

Indexed keywords

ANTIBIOTIC AGENT; C REACTIVE PROTEIN;

ACUTE DISEASE; ADENOVIRUS; ADULT; ANTIBIOTIC THERAPY; ARTICLE; CONTROLLED STUDY; CYSTIC FIBROSIS; DISEASE ASSOCIATION; DISEASE EXACERBATION; DISEASE SEVERITY; FEMALE; FORCED EXPIRATORY VOLUME; FORCED VITAL CAPACITY; HOSPITAL BASED CASE CONTROL STUDY; HUMAN; INFLUENZA; INFLUENZA B; INFLUENZA VIRUS A H1N1; LUNG DISEASE; LUNG FUNCTION; MAJOR CLINICAL STUDY; MALE; METAPNEUMOVIRUS; NEUTROPHIL COUNT; PARAINFLUENZA VIRUS 1; POLYMERASE CHAIN REACTION; RESPIRATORY SYNCYTIAL PNEUMOVIRUS; RESPIRATORY VIRUS; RETROSPECTIVE STUDY; RHINOVIRUS; THROAT CULTURE; TREATMENT RESPONSE; VIRUS ISOLATION;

CYSTIC FIBROSIS; POLYMERASE CHAIN REACTION; PULMONARY EXACERBATION; RESPIRATORY VIRUSES; RHINOVIRUS;

ADULT; ANTI-BACTERIAL AGENTS; CASE-CONTROL STUDIES; CYSTIC FIBROSIS; FEMALE; HUMANS; INFLUENZA A VIRUS; INFLUENZA A VIRUS, H1N1 SUBTYPE; INFLUENZA B VIRUS; INFLUENZA, HUMAN; INFUSIONS, INTRAVENOUS; MALE; PARAMYXOVIRIDAE INFECTIONS; PICORNAVIRIDAE INFECTIONS; PNEUMONIA, BACTERIAL; PREVALENCE; RESPIRATORY TRACT INFECTIONS; RETROSPECTIVE STUDIES; RHINOVIRUS; SEVERITY OF ILLNESS INDEX; VIRUS DISEASES; YOUNG ADULT;

EID: 84890437567     PISSN: 15691993     EISSN: 18735010     Source Type: Journal    
DOI: 10.1016/j.jcf.2013.06.004     Document Type: Article

References (41)

1. Emerson J., Rosenfeld M., McNamara S., Ramsey B., Gibson R.L. Pseudomonas aeruginosa and other predictors of mortality and morbidity in young children with cystic fibrosis. Pediatr Pulmonol 2002, 34(2):91-100.
2. Wang E.E., Prober C.G., Manson B., Corey M., Levison H. Association of respiratory viral infections with pulmonary deterioration in patients with cystic fibrosis. N Engl J Med 1984, 311(26):1653-1658.
3. Ramsey B.W., Gore E.J., Smith A.L., Cooney M.K., Redding G.J., Foy H. The effect of respiratory viral infections on patients with cystic fibrosis. Am J Dis Child 1989, 143(6):662-668.
4. Hiatt P.W., Grace S.C., Kozinetz C.A., Raboudi S.H., Treece D.G., Taber L.H., et al. Effects of viral lower respiratory tract infection on lung function in infants with cystic fibrosis. Pediatrics 1999, 103(3):619-626.
5. van Ewijk B.E., van der Zalm M.M., Wolfs T.F., Fleer A., Kimpen J.L., Wilbrink B., et al. Prevalence and impact of respiratory viral infections in young children with cystic fibrosis: prospective cohort study. Pediatrics 2008, 122(6):1171-1176.
6. Pribble C.G., Black P.G., Bosso J.A., Turner R.B. Clinical manifestations of exacerbations of cystic fibrosis associated with nonbacterial infections. J Pediatr 1990, 117(2 Pt 1):200-204.
7. Smyth A.R., Smyth R.L., Tong C.Y., Hart C.A., Heaf D.P. Effect of respiratory virus infections including rhinovirus on clinical status in cystic fibrosis. Arch Dis Child 1995, 73(2):117-120.
8. Wat D., Gelder C., Hibbitts S., Cafferty F., Bowler I., Pierrepoint M., et al. The role of respiratory viruses in cystic fibrosis. J Cyst Fibros 2008, 7(4):320-328.
9. Burns J.L., Emerson J., Kuypers J., Campbell A.P., Gibson R.L., McNamara S., et al. Respiratory viruses in children with cystic fibrosis: viral detection and clinical findings. Influenza Other Respir Viruses 2012, 6(3):218-223.
10. Asner S., Waters V., Solomon M., Yau Y., Richardson S.E., Grasemann H., et al. Role of respiratory viruses in pulmonary exacerbations in children with cystic fibrosis. J Cyst Fibros 2012, 11(5):433-439.
11. Peterson N.T., Hoiby N., Mordhorst C.H., Lind K., Flensborg E.W., Bruun B. Respiratory infections in cystic fibrosis patients caused by virus, chlamydia and mycoplasma - possible synergism with Pseudomonas aeruginosa. Acta Paediatr Scand 1981, 70(5):623-628.
12. Ong E.L., Ellis M.E., Webb A.K., Neal K.R., Dodd M., Caul E.O., et al. Infective respiratory exacerbations in young adults with cystic fibrosis: role of viruses and atypical microorganisms. Thorax 1989, 44(9):739-742.
13. Armstrong D., Grimwood K., Carlin J.B., Carzino R., Hull J., Olinsky A., et al. Severe viral respiratory infections in infants with cystic fibrosis. Pediatr Pulmonol 1998, 26(6):371-379.
14. Clifton I.J., Kastelik J.A., Peckham D.G., Hale A., Denton M., Etherington C., et al. Ten years of viral and non-bacterial serology in adults with cystic fibrosis. Epidemiol Infect 2008, 136(1):128-134.
15. Templeton K.E., Scheltinga S.A., Beersma M.F., Kroes A.C., Claas E.C. Rapid and sensitive method using multiplex real-time PCR for diagnosis of infections by Influenza A and Influenza B viruses, Respiratory syncytial virus and Parainfluenza viruses 1,2,3 and 4. J Clin Microbiol 2004, 42(4):1564-1569.
16. Wark P.A., Tooze M., Cheese L., Whitehead B., Gibson P.G., Wark K.F., et al. Viral infections trigger exacerbations of cystic fibrosis in adults and children. Eur Respir J 2012, 40(2):510-512.
17. Lee T.W., Brownlee K.G., Conway S.P., Denton M., Littlewood J.M. Evaluation of a new definition for chronic Pseudomonas aeruginosa infection in cystic fibrosis patients. J Cyst Fibros 2003, 2(1):29-34.
18. Johnston S.L., Pattermore P.K., Sanderson G., Smith S., Lampe F., Josephs L., et al. Community study of role of viral infections in exacerbations of asthma in 9-11year old children. BMJ 1995, 310(6989):1225-1229.
19. Tan W.C., Xiang X., Qiu D., Ng T.P., Lam S.F., Hegele R.G. Epidemiology of respiratory viruses in patients hospitalized with near-fatal asthma, acute exacerbations of asthma, or chronic obstructive pulmonary disease. Am J Med 2003, 115(4):272-277.
20. Monto A.S. Epidemiology of viral respiratory infections. Am J Med 2002, 112(Suppl. 6A):4S-12S.
21. Johansen H.K., Hoiby N. Seasonal onset of initial colonisation and chronic infection with Pseudomonas aeruginosa in patients with cystic fibrosis in Denmark. Thorax 1992, 47(2):109-111.
22. Ortiz J.R., Neuzil K.M., Victor J.C., Wald A., Aitken M.L., Goss C.H. Influenza-associated cystic fibrosis pulmonary exacerbations. Chest 2010, 137(4):852-860.
23. Papadopoulos N.G., Bates P.J., Bardin P.G., Papi A., Leir S.H., Fraenkel D.J., et al. Rhinoviruses infect the lower airways. J Infect Dis 2000, 181(6):1875-1884.
24. de Almeida M.B., Zerbinati R.M., Tateno A.F., Oliveira C.M, Romao R.M., Rodrigues J.C., et al. Rhinovirus C and respiratory exacerbations in children with cystic fibrosis. Emerg Infect Dis 2010, 16(6):996-999.
25. Nash E.F., Whitmill R., Barker B., Rashid R., Whitehouse J.L., Honeybourne D. Clinical outcomes of pandemic (H1N1) 2009 influenza (swine flu) in adults with cystic fibrosis. Thorax 2011, 66(3):259.
26. Colombo C., Battezzati P.M., Lucidi V., Magazzu G., Motta V., Alicandro G., et al. Influenza A/H1N1 in patients with cystic fibrosis in Italy: a multicentre cohort study. Thorax 2011, 66(3):260-261.
27. Viviani L., Assael B.M., Kerem E. Impact of the A (H1N1) pandemic influenza (season 2009-2010) on patients with cystic fibrosis. J Cyst Fibros 2011, 10(5):370-376. ECFS (A) H1N1 study group.
28. van Ewijk B.E., van der Zalm M.M., Wolfs T.S., van der Ent C.K. Viral respiratory infections in cystic fibrosis. J Cyst Fibros 2005, 4(Suppl. 2):31-36.
29. Vareille M., Kieninger E., Edwards M.R., Regamey N. The airway epithelium: soldier in the fight against respiratory viruses. Clin Microbiol Rev 2011, 24(1):210-229.
30. Sutanto E.N., Kicic A., Foo C.J., Stevens P.T., Mullane D., Knight D.A., et al. Innate inflammatory responses of pediatric cystic fibrosis airway epithelial cells: effects of nonviral and viral stimulation. Am J Respir Cell Mol Biol 2011, 44(6):761-767.
31. Zheng S., Xu W., Bose S., Banergee A.K., Haque S.J., Erzurum S.C. Impaired nitric oxide synthetase-2 signaling pathway in cystic fibrosis airway epithelium. Am J Physiol Lung Cell Mol Physiol 2004, 287(2):374-381.
32. van Ewijk B.E., Wolfs T.S., Aerts P.C., van Kessel K.P., Fleer A., Kimpen J.L., et al. RSV mediates Pseudomonas aeruginosa binding to cystic fibrosis and normal epithelial cells. Pediatr Res 2007, 61(4):398-403.
33. Vareille M., Kieninger E., Alves M.P., Kopf B.S., Moller A., Geiser T., et al. Impaired type I and type III interferon induction and rhinovirus control in human cystic fibrosis airway epithelial cells. Thorax 2012, 67(6):517-525.
34. Malfroot A., Adam G., Ciofu O., Doring G., Knoop C., Lang A.B., et al. Immunisation in the current management of cystic fibrosis patients. J Cyst Fibros 2005, 4(2):77-87.
35. Ong E.L., Bilton D., Abbott J., Webb A.K., McCartney R.A., Caul E.O. Influenza vaccination in adults with cystic fibrosis. BMJ 1991, 303(6802):557.
36. Dharmaraj P., Smyth R.L. Vaccines for preventing influenza in people with cystic fibrosis. Cochrane Database Syst Rev 2009, 4:CD001753.
37. Wat D., Gelder C., Hibbitts S., Bowler I., Pierrepoint M.E.R., et al. Is there a role for influenza vaccination in cystic fibrosis?. J Cyst Fibros 2008, 7(1):85-88.
38. McCormick J., Southern K.W. A survey of palivizumab for infants with cystic fibrosis in the UK. Arch Dis Child 2007, 92(1):87-88.
39. Robinson K.A., Odelola O.A., Saldanha I.J., Mckoy N.A. Palivizumab for prophylaxis against respiratory syncytial virus infection in children with cystic fibrosis. Cochrane Database Syst Rev 2013, 6:CD007743.
40. Rohde G.G. Rhinovirus vaccination: the case in favour. Eur Respir J 2011, 37(1):3-4.
41. Papi A., Contoli M. Rhinovirus vaccination: the case against. Eur Respir J 2011, 37(1):5-7.